Massive Intra-Tumor Hemorrhage during Induction Chemotherapy in Neuroblastoma: A Case Series Report
Journal Title: Journal of Cancer Sciences - Year 2017, Vol 4, Issue 1
Abstract
We describe 5 children with high risk neuroblastoma (NB) who, during the induction phase of therapy, were admitted with circulatory shock because of massive intra-tumor bleeding. Patient’s intensive supportive care with fluid resuscitation, blood and blood product’s transfusion succeeded to restore hemodynamic stability. Surgical intervention to control bleeding was necessary in two of the children. All children survived the massive hemorrhage to continue their treatment as per protocol. Overall prognosis was not affected by this incident.
Authors and Affiliations
Abeer Al-Diab
Keywords
Related Articles
- EP ID EP246878
- DOI 10.13188/2377-9292.1000015
- Views 105
- Downloads 0
Constitutive Developmental Modeling of Genomic Integrityand Epigenetic Interactivity in Neuroblastoma
The essential formulas of possible progression or non-progression are dimensionally and potentially highly divergent systems of operative aggressive growth and spread of a neuroblastoma. As such, an essential integrity o...
The Association amongst ‘Triple Negative’ Breast Cancers, Lymph Node Metastasis, Disease Free and Overall Survival
Triple negative’ breast cancer (TNBC) has fewer specific targets for systemic therapy. We hypothesized that patients with TNBC have an increased incidence of sentinel lymph node (SLN) metastases and decreased disease-spe...
Massive Intra-Tumor Hemorrhage during Induction Chemotherapy in Neuroblastoma: A Case Series Report
We describe 5 children with high risk neuroblastoma (NB) who, during the induction phase of therapy, were admitted with circulatory shock because of massive intra-tumor bleeding. Patient’s intensive supportive care with...
Gemcitabine-Capecitabine Chemotherapy Plus Intra- Arterial Epirubicin-Cisplatin in Pancreatic Cancer Patients after FOLFIRINOX First Line Chemotherapy: A Retrospective Analysis
Background: Most pancreatic cancer patients have disease recurrence/progression within 6 months from firstline chemotherapy end. Today, there is no a standard of care of second-line therapy. Materials (patients) and me...
White Adipose Tissue Browning and Cancer Cachexia
Cachexia or wasting syndrome is often seen in cancer patients. Over half of the patients suffer from this condition although the incidence varies from tumor types. Symptoms of cancer cachexia include progressive weight l...